Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype.

doi:10.1093/jac/dku372

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype.

The Journal of antimicrobial chemotherapy - 1 Jan 2015

Parczewski Miłosz, Leszczyszyn-Pynka Magdalena, Witak-Jędra Magdalena, Maciejewska Katarzyna, Rymer Weronika, Szymczak Aleksandra, Szetela Bartosz, Gąsiorowski Jacek, Bociąga-Jasik Monika, Skwara Paweł, Garlicki Aleksander, Grzeszczuk Anna, Rogalska Magdalena, Jankowska Maria, Lemańska Małgorzata, Hlebowicz Maria, Barałkiewicz Grażyna, Mozer-Lisewska Iwona, Mazurek Renata, Lojewski Władyslaw, Grąbczewska Edyta, Olczak Anita, Jabłonowska Elżbieta, Clark Jeremy, Urbańska Anna

Abstract excerpt

OBJECTIVES: The surveillance of HIV-transmitted drug resistance mutations (t-DRMs), including temporal trends across subtypes and exposure groups, remains a priority in the current management of the epidemic worldwide. METHODS: A cross-sectional analysis of 833 treatment-naive patients from 9 of 17 Polish HIV treatment centres. Partial pol sequences were used to analyse drug resistance with a general time...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Drug Resistance, Viral

Share to HIV

Share to HIV Infections

Share to Mutation Rate

Share to pol Gene Products, Human Immunodeficiency Virus

Share to Poland

Source

Open in PubMed

Identifiers

PMID: 25248322
DOI: 10.1093/jac/dku372

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype.PMID 25248322Read ↗

Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnosesSemantic proximity Read ↗

Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14.Semantic proximity Read ↗

Evolving patterns of HIV-1 transmitted drug resistance in Poland in the years 2000-2008.Semantic proximity Read ↗

Transmitted drug resistance to rilpivirine among antiretroviral-naïve patients living with HIV from northern Poland.Semantic proximity Read ↗

Distribution and time trends of HIV-1 variants in Poland: Characteristics of non-B clades and recombinant viruses.Semantic proximity Read ↗

Transmitted HIV drug resistance in treatment-naive Romanian patients.Semantic proximity Read ↗

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in FranceSemantic proximity Read ↗

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.Semantic proximity Read ↗

Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk GroupSemantic proximity Read ↗

Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.Semantic proximity Read ↗

Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece.Semantic proximity Read ↗

Evaluating HIV-1 Transmitted Drug Resistance and Clustering in Newly Diagnosed Patients in Romania (2019-2022).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.